Table 2.
Univariate Analysis | Multivariate Analysis | |||
---|---|---|---|---|
Parameters | OR, %95 CI | p Value | OR, %95 CI | p Value |
Age | 1.02 (0.99–1.04) | 0.132 | 1.051 (1.014–1.089) | 0.007 |
Female | 1.23 (0.81–1.85) | 0.336 | ||
HT | 2.21 (1.38–3.56) | <0.001 | 1.91 (0.97–3.75) | 0.062 |
DM | 4.49 (3.03–6.66) | <0.001 | 4.87 (2.82–8.42) | <0.001 |
CAD | 1.71 (1.12–2.61) | 0.013 | ||
PD | 2.65 (1.05–6.59) | 0.038 | 0.380 (0.128–1.135) | 0.088 |
TG | 1.00 (1.00–1.01) | 0.042 | ||
HDL | 0.97 (0.95–0.98) | <0.001 | 0.982 (0.96–1.001) | 0.066 |
HbA1c | 1.44 (1.24–1.67) | <0.001 | ||
Number of Drugs | 1.12 (1.07–1.18) | <0.001 | ||
Hemoglobin | 0.83 (0.74–0.93) | <0.001 | ||
Insomnia | 1.13 (0.78–1.64) | 0.504 | ||
EDS | 1.74 (1.16–2.62) | 0.008 | 1.96 (1.15–3.33) | 0.013 |
Binary logistic regression analysis was used. The variables that were statistically significant in univariate analysis were included in the multivariate analysis. The backward LR variable selection method was used, and the final results were given in multivariate analysis. CAD: Coronary Artery Disease; CI: Confidence Interval; DM: Diabetes Mellitus, EDS: Excessive Daytime Sleepiness; HDL: High-Density Lipoprotein; HT: Hypertension; PD: Parkinson’s Disease; TG: Triglyceride. Nagelkerke R square value was obtained as 0.215. Hosmer and Lemeshow test p value was obtained as 0.250.